Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Natera, Inc. (NTRA : NSDQ)

• Company Description    Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. Number of Employees: 4,434

• Price / Volume Information    Yesterday's Closing Price: $200.17 Daily Weekly Monthly 20 Day Moving Average: 1,162,477 shares Shares Outstanding: 141.73 (millions) Market Capitalization: $28,370.34 (millions) Beta: 1.65 52 Week High: $256.36 52 Week Low: $125.38 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.38% -12.19% 12 Week -16.30% -16.72% Year To Date -12.62% -13.08%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 13011 McCallen Pass Building A Suite 100 - Austin,TX 78753 USA ph: 650-980-9190 fax: - investor@natera.com http://www.natera.com

• General Corporate Information    Officers Steve Chapman - Chief Executive Officer and President Matthew Rabinowitz - Executive Chairman Michael Brophy - Chief Financial Officer Roy Baynes - Director Monica Bertagnolli - Director Peer Information Natera, Inc. (CHCR) Natera, Inc. (ESRX) Natera, Inc. (MYDP) Natera, Inc. (COR) Natera, Inc. (GBCS) Natera, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 632307104 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/14/26 Share - Related Items Shares Outstanding: 141.73 Most Recent Split Date: (:1) Beta: 1.65 Market Capitalization: $28,370.34 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.52 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.66 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/14/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 21.94 Price/Cash Flow: - Price / Sales: 12.30 EPS Growth vs. Year Ago Period: 185.37% vs. Previous Quarter: 154.69% Sales Growth vs. Year Ago Period: 39.79% vs. Previous Quarter: 12.38% ROE 12/31/25 - -16.71 09/30/25 - -25.07 06/30/25 - -22.22 ROA 12/31/25 - -11.76 09/30/25 - -17.74 06/30/25 - -15.03 Current Ratio 12/31/25 - - 09/30/25 - 3.27 06/30/25 - 3.72 Quick Ratio 12/31/25 - - 09/30/25 - 3.13 06/30/25 - 3.58 Operating Margin 12/31/25 - -9.03 09/30/25 - -14.61 06/30/25 - -12.89 Net Margin 12/31/25 - -9.03 09/30/25 - -14.61 06/30/25 - -12.89 Pre-Tax Margin 12/31/25 - - 09/30/25 - -14.64 06/30/25 - -12.90 Book Value 12/31/25 - - 09/30/25 - 9.12 06/30/25 - 9.13 Inventory Turnover 12/31/25 - - 09/30/25 - 14.38 06/30/25 - 14.73 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©